Cocrystal Pharma, Inc.
(NASDAQ : COCP)

( )
COCP PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Generic
symbolcompany%chnglast%shortavg$volume
AGNAllergan plc
-1.86%135.482.8%$291.51m
MYLMylan N.V.
-0.99%18.983.2%$183.09m
ZTSZoetis, Inc. Class A
-0.54%102.341.9%$179.05m
TEVATeva Pharmaceutical Industries Limited Sponsored ADR
-1.63%10.862.0%$170.32m
TXMDTherapeuticsMD, Inc.
3.25%3.1824.9%$11.87m
PETXAratana Therapeutics, Inc.
-0.83%4.768.5%$9.82m
TAROTaro Pharmaceutical Industries Ltd.
-0.84%93.866.4%$6.92m
RDYDr. Reddy's Laboratories Ltd. Sponsored ADR
1.25%38.162.0%$5.97m
ABEOAbeona Therapeutics, Inc.
0.92%6.557.6%$2.50m
KINKindred Biosciences, Inc.
0.95%8.500.3%$1.48m
LFVNLifeVantage Corporation
0.81%11.213.3%$1.13m
JAGXJaguar Animal Health, Inc.
1.24%0.179.8%$0.52m
CPHIChina Pharma Holdings, Inc.
0.39%0.290.1%$0.09m

Company Profile

Cocrystal Pharma, Inc. is a biotechnology company, which engages in the discovery and development of novel antiviral therapeutics. It focuses on the preclinical and early clinical stage antiviral compounds for unmet medical needs including influenza, Hepatitis C virus, and norovirus infections. The company was founded on January 2, 2014 and is headquartered in Bothell, WA.